Craig Lipset, Decentralized Clinical Trial Pioneer and Industry Innovator, Named as MedVector Board Member and Executive Advisor

LOS ANGELES…June 17, 2021 — Craig Lipset, a clinical trials industry innovator and leader, has joined the MedVector team as a new board member and executive advisor. MedVector’s novel Prime-Control Technology platform unlocks access to millions of potential clinical trial participants who are seen every day by physicians who are not seeking to become study…

MedVector Unveils Prime-Control Technology to Expand Subject Enrollment in Clinical Trials

MedVector introduces its Prime-Controltm Technology to provide contract research organizations and pharmaceutical sponsors with access to subjects for new clinical trials. FREMONT, CA: MedVector has begun a nationwide rollout of its Prime-Controltm Technology, which will provide contract research organizations (CROs) and pharmaceutical sponsors with access to numerous patients without the requirement of new clinical trial sites.…

MedVector Launches its Prime-Control Technology to Expand Subject Enrollment Beyond Clinical Trial Sites

March 25, 2021 – MedVector has begun the rollout of its Prime-Controltm Technology, to give contract research organizations (CROs) and pharma sponsors access to patients without triggering new clinical trial sites. MedVector is the only company that partners with CROs, sponsors, and patient recruitment companies to expand subject participation beyond existing clinical trial sites. Clinical…